ATE406888T1 - Cyanoacrylat-zusammensetzungen für die therapeutische behandlungvon wunden, die eine revision erfordern - Google Patents

Cyanoacrylat-zusammensetzungen für die therapeutische behandlungvon wunden, die eine revision erfordern

Info

Publication number
ATE406888T1
ATE406888T1 AT02740028T AT02740028T ATE406888T1 AT E406888 T1 ATE406888 T1 AT E406888T1 AT 02740028 T AT02740028 T AT 02740028T AT 02740028 T AT02740028 T AT 02740028T AT E406888 T1 ATE406888 T1 AT E406888T1
Authority
AT
Austria
Prior art keywords
therapeutic treatment
exanthemas
cyanoacrylate compositions
requiring revision
revision
Prior art date
Application number
AT02740028T
Other languages
English (en)
Inventor
Hans Brinch Lyster
Original Assignee
Hans Brinch Lyster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK200100068A external-priority patent/DK176041B1/da
Priority claimed from DK200100264A external-priority patent/DK176050B1/da
Application filed by Hans Brinch Lyster filed Critical Hans Brinch Lyster
Application granted granted Critical
Publication of ATE406888T1 publication Critical patent/ATE406888T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02740028T 2001-01-16 2002-01-16 Cyanoacrylat-zusammensetzungen für die therapeutische behandlungvon wunden, die eine revision erfordern ATE406888T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK200100068A DK176041B1 (da) 2001-01-16 2001-01-16 Medikament indeholdende cyanoacrylatforbindelser til brug ved revision af sår i humant eller animalsk væv
DKPA200100067 2001-01-16
DK200100264A DK176050B1 (da) 2001-02-16 2001-02-16 Medikament til behandling af udslæt i humant dermatöst eller mucöst væv

Publications (1)

Publication Number Publication Date
ATE406888T1 true ATE406888T1 (de) 2008-09-15

Family

ID=27222479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02740028T ATE406888T1 (de) 2001-01-16 2002-01-16 Cyanoacrylat-zusammensetzungen für die therapeutische behandlungvon wunden, die eine revision erfordern

Country Status (10)

Country Link
US (1) US20040175353A1 (de)
EP (1) EP1363617B1 (de)
JP (1) JP2004520391A (de)
AT (1) ATE406888T1 (de)
CA (1) CA2434079A1 (de)
DE (1) DE60228687D1 (de)
DK (1) DK1363617T3 (de)
MX (1) MXPA03006346A (de)
NZ (1) NZ526967A (de)
WO (1) WO2002062331A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041686A2 (en) * 2001-11-14 2003-05-22 Medlogic Global Limited Improved therapy for topical diseases
US20090036531A1 (en) * 2005-02-22 2009-02-05 Nguyen Tim T Method for treatment of onychomycosis
WO2015129793A1 (ja) * 2014-02-27 2015-09-03 昇一 城武 抗ウイルス剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3866098D1 (de) * 1988-01-07 1991-12-12 Exovir Inc Kosmetische hautbehandlung.
US5306490A (en) * 1992-04-20 1994-04-26 Medlogic, Inc. Methods for retarding blister formation by use of cyanoacrylate adhesives
WO1993025196A1 (en) * 1992-06-09 1993-12-23 Medlogic, Inc. Methods for treating non-suturable wounds by use of cyanoacrylate adhesives
US5403591A (en) * 1993-06-25 1995-04-04 Medlogic Global Corporation Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives
WO1997047310A1 (fr) * 1996-06-12 1997-12-18 Stoa S.A. Compositions pharmaceutiques a base de gels de type glyceryl poly(meth)acrylate
WO1998003152A1 (fr) * 1996-07-19 1998-01-29 Sederma S.A. Compositions pour le traitement des erythemes solaires et des affections buccales
US20010051179A1 (en) * 1996-09-20 2001-12-13 Charles L. Berman Method for preventing the spread of infectious microorganisms using cyanoacrylate
US6310166B1 (en) * 1999-08-12 2001-10-30 Closure Medical Corporation Sterilized cyanoacrylate solutions containing thickeners

Also Published As

Publication number Publication date
US20040175353A1 (en) 2004-09-09
EP1363617B1 (de) 2008-09-03
EP1363617A1 (de) 2003-11-26
DE60228687D1 (de) 2008-10-16
MXPA03006346A (es) 2005-02-14
NZ526967A (en) 2005-01-28
DK1363617T3 (da) 2009-01-26
WO2002062331A1 (en) 2002-08-15
CA2434079A1 (en) 2002-08-15
JP2004520391A (ja) 2004-07-08

Similar Documents

Publication Publication Date Title
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
WO2002011764A3 (en) PHARMACEUTICAL COMPOSITIONS
ATE291433T1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
WO2003039444A3 (de) Topikale verwendung von cytokinen und/oder chemokinen zur behandlung von viralen oder mykotischen hauterkrankungen oder tumorerkrankungen
EE05357B1 (et) Tablett, mis sisaldab v„hemalt kahte eristatavat segmenti, ning selle kasutamine
DE60229235D1 (de) D kupfersulfaten und sucralphat
MA27059A1 (fr) Azithromycine en dose unique
PT1343472E (pt) Pulverizacao nasal tixotropica
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
ATE406888T1 (de) Cyanoacrylat-zusammensetzungen für die therapeutische behandlungvon wunden, die eine revision erfordern
BR0313589A (pt) Uso de extrato de germe de trigo fermentado como agente antiinflamatório
SE0000303D0 (sv) Novel compounds
BR0210910A (pt) Derivados de imidazotriazinonas e sua aplicação contra processos inflamatórios e/ou doenças imunes
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
DE50203154D1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
HUP0402624A2 (hu) Vírusgátlás n-dokozanollal
PT1232173E (pt) Derivados do acido fusidico
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties